Skip to main content

Data Model Praklinis NAFLD/NASH akan Disajikan pada ADA 2020

Written by Customer Service on . Posted in Public Companies.

SAN DIEGO, June 10, 2020 (GLOBE NEWSWIRE) — Crown Bioscience hari ini mengumumkan presentasi data pengembangan model praklinis paten NAFLD/NASH baru. Data ini akan tersedia pada Sesi Ilmiah American Diabetes Association (ADA) ke-80, serta acara virtual pelengkap milik CrownBio.
Data baru ini merupakan pengembangan model NAFLD/NASH yang dihasilkan melalui modifikasi pola makan di repertoar CrownBio dari model praklinis NHP dan hewan pengerat yang sangat translasional. Model-model tersebut akan mendukung pengembangan obat NAFLD/NASH praklinis yang ditingkatkan, area penyakit yang saat ini belum memiliki terapi yang disetujui.Selain poster ADA 2020, CrownBio juga mendukung Hari NASH Internasional bersamaan pada tanggal 12 Juni dengan presentasi pengembangan model NAFLD/NASH. CrownBio menyelenggarakan acara virtual gratis, menyediakan akses ke semua sumber daya ini, yang terdaftar di CrownBio.com/ADA20.“Kami berkomitmen untuk melanjutkan dan mempercepat penelitian NAFLD/NASH, dengan terus meningkatkan platform model praklinis kami yang sangat translasional,” ujar Dr. Jim Wang, Senior Vice President Cardiovascular and Metabolic Disease di CrownBio. “Kami senang dapat berbagi penelitian terbaru kami di bidang berkebutuhan tinggi ini di berbagai acara virtual inovatif pada Juni ini.”Kegiatan ADA virtual CrownBio berlangsung dari 12 hingga 16 Juni di CrownBio.com/ADA20, dan akan melakukan diskusi dengan tim penyakit metabolik dan kardiovaskular CrownBio, serta peninjauan dan pengunduhan berbagai sumber daya di seluruh area penyakit termasuk NAFLD/NASH, diabetes, obesitas, ginjal, dan kardiovaskular.Tentang Crown Bioscience Inc.Crown Bioscience, perusahaan JSR Life Sciences, merupakan perusahaan layanan penemuan dan pengembangan obat global yang menyediakan platform translasional untuk memajukan penelitian onkologi, peradangan, dan penyakit metabolik. Dengan beragam portofolio model dan alat prediktif yang relevan, Crown Bioscience dapat menyediakan kandidat klinis yang unggul kepada klien. Untuk informasi selengkapnya, kunjungi:https://www.crownbio.comhttps://www.jsrlifesciences.comPertanyaan Media:Crown Bioscience 
 Jody Barbeau
pr@crownbio.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.